Previous 10 | Next 10 |
CLGN's platform-technology is underscored by its recent AbbVie partnership. Royalty model company that is debt-free, and well funded. Recent partnership with 3D Systems creates end-to-end bioprinting partnership with multiple end-market opportunities to pursue. Company current...
NetworkNewsWire Editorial Coverage New York, NY – August 5, 2021 – A leading cause of death in the United States for men and women of most racial and ethnic groups, heart disease is a pervasive health challenge that destroys lives. The Centers for Disea...
Specialty pharmaceutical-company United Therapeutics (NASDAQ: UTHR) was an outlier stock in the best way on Wednesday. After reporting quarterly figures showing revenue growth in all of its products, the shares closed the day over 14% higher. United Therapeutics took in $446.5 m...
United Therapeutics Corporation (UTHR) Q2 2021 Earnings Conference Call August 4, 2021 09:00 ET Company Participants Dewey Steadman - Head, Investor Relations Martine Rothblatt - Chairperson and Chief Executive Officer Michael Benkowitz - President and Chief Operating Officer James Edgemond -...
Image source: The Motley Fool. United Therapeutics Corporation (NASDAQ: UTHR) Q2 2021 Earnings Call Aug 4, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call...
United Therapeutics Corporation Reports Second Quarter 2021 Financial Results Tyvaso® (treprostinil) Inhalation Solution net revenue growth of 29% year over year; total net revenue growth of 23% year over year Tyvaso DPI™ NDA under review with FDA action expected...
United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 3, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced t...
United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021 PR Newswire SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 28, 2021 /PRNewswire/ -- United Therapeutics Corpo...
Because the spread of the coronavirus Delta variant in several countries is becoming a major concern, the biotech industry is expected to continue attracting investors’ attention. The industry’s role in finding cures for various other diseases should also sustain investorsȁ...
United Therapeutics (UTHR) announces the publication of a post-hoc analysis of forced vital capacity ((FVC)) change in patients during the INCREASE study of Tyvaso (treprostinil) Inhalation Solution in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD...
News, Short Squeeze, Breakout and More Instantly...
United Therapeutics Corporation Company Name:
UTHR Stock Symbol:
NASDAQ Market:
United Therapeutics Corporation Website:
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...
2024-07-11 06:30:06 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for UTHR on July 11, 2024 04:53AM ET. The previous analyst recommendation was Overweight. UTHR was trading at $329.25 at issue of the analyst recommendation. The overall analyst consensus : ...
Over 100,000 patients in the United States have IPF, with two approved therapies available that only slow the course of disease progression Top line data expected in the second half of 2025 United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announ...